Iso-α-acids have been found to activate peroxisome-proliferator-activated receptor-g (PPAR-g)2, a known therapeutic target in Alzheimer’s disease (AD), highlighting a possible role of these compounds on the pathogenesis of AD [34,35]. The gene discussed is PPARG; the disease is Alzheimer disease.